Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015
Year: 2007
Type: article
Study design: Clinical Trial
Source: Annals of Oncology
Institutions: Klinikum Oldenburg, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, University of Tübingen, National Institute of Oncology, AZ Groeninge, Asklepios Klinik Altona, ZNA Middelheim Hospital, AZ Turnhout, University Medical Center Hamburg-Eppendorf, Universitätsklinikum Würzburg, Westpfalz Klinikum, Vivantes Klinikum, Kliniken Essen-Mitte, Institut Jules Bordet, Antwerp University Hospital, European Organisation for Research and Treatment of Cancer, European Organisation for Research and Treatment of Cancer, Universitair Ziekenhuis Leuven
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2165429160
